Delivery Order 47QSWA20D007S-75H71124F80159

Award Date 9/7/24
Potential Completion Date 6/30/25
Potential Value $23K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lawton, OK 73507, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Indian Health Service (IHS), a civilian agency within the U.S. Department of Health and Human Services, to Medtox Laboratories Inc., a division of Laboratory Corporation of America Holdings. The $26,419.76 firm fixed-price delivery order was issued against Medtox's Multiple Award Schedule (MAS) contract with the General Services Administration (GSA). It provides for the delivery of medtox drug screening supplies to support the IHS Laboratory Department's...
This is a firm fixed-price purchase order awarded by the Indian Health Service (IHS), a division of the Department of Health and Human Services, to Medtox Diagnostics, Inc., a manufacturer of laboratory testing products and services. The contract, valued at $27,500.60, is for the delivery of drugs of abuse testing supplies to support direct patient care activities and drug screening for Native American populations served by IHS facilities. The award has no set-aside designation, indicating...
This federal contract award is for a one-year supply of drugs of abuse reagents for the Indian Health Service (IHS) Pine Ridge Service Unit. The $58,719.94 firm fixed-price delivery order was issued to Medtox Laboratories Inc., a division of Laboratory Corporation of America Holdings, under the company's Multiple Award Schedule (MAS) contract with the General Services Administration. The supplies, which include drug screening test kits and analyzer test cartridges, will be delivered between...
Medtox Laboratories Inc., a division of Laboratory Corporation of America Holdings, has received a $46,457.76 delivery order from the Department of Health and Human Services Indian Health Service (IHS) for laboratory equipment and supplies. The firm fixed price order was issued against Medtox's Law Enforcement & Security Services (FSS-84) Multiple Award Schedule contract with the General Services Administration, with no set-aside designation. The products will be delivered to the IHS...
This firm fixed-price purchase order (PO) was awarded by the Indian Health Service (IHS), a division of the Department of Health and Human Services, to Medtox Diagnostics, Inc., a subsidiary of Laboratory Corporation of America Holdings (LabCorp). The $156,528.79 contract is for urine drug screening and confirmatory testing services to support clinical testing and healthcare services for Native American communities. No set-aside designation was used. LabCorp, a global life sciences company,...
The Department of Health and Human Services Indian Health Service awarded a $28,475 firm fixed price delivery order against the Multiple Award Schedule contract vehicle to Medtox Laboratories, Inc. for drug screen services. Medtox Laboratories, Inc. is a division of Laboratory Corporation of America Holdings and will perform the drug screens in Lawton, Oklahoma by the October 31, 2020 completion date. No set-aside designation was used for this contract. The Indian Health Service supports...
The Department of Health and Human Services Indian Health Service awarded a $113,500 firm fixed price delivery order against the Multiple Award Schedule contract vehicle to Medtox Laboratories, Inc. for drug screening testing kits. Performance will take place in Shiprock, New Mexico through August 2026. Medtox Laboratories, Inc. is a division of the prime contractor Laboratory Corporation of America Holdings, which maintains a GSA Schedule contract for laboratory supplies and services supporting...
This federal contract award to Medtox Diagnostics, Inc., a subsidiary of Laboratory Corporation of America Holdings, is a Blanket Purchase Agreement (BPA) to procure miscellaneous laboratory supplies for the Indian Health Service (IHS), a division of the Department of Health and Human Services. The $13,184.87 firm fixed price contract has a completion date of January 31, 2023. Medtox Diagnostics, a manufacturer of laboratory testing products and services, primarily provides drugs of abuse...
The Department of Health and Human Services Indian Health Service awarded a $10,153 firm fixed price delivery order against the Multiple Award Schedule to Medtox Laboratories, Inc. for drug screens. Medtox Laboratories, Inc. is a division of Laboratory Corporation of America Holdings and will perform the drug screens in Lawton, Oklahoma by the February 28, 2021 completion date. No set aside designation was used for this contract awarded on December 31, 2020 under the GSA Schedule for...
Medtox Laboratories Inc., a subsidiary of Laboratory Corporation of America Holdings, was awarded a $10,133.10 firm fixed price delivery order against the Multiple Award Schedule contract vehicle. The contract calls for Medtox to provide drug profiles and supplies in support of the Lawton Indian Hospital, part of the Indian Health Service within the Department of Health and Human Services. No set-aside designation was used for this award. Performance will occur in Burlington, North Carolina as...

This federal contract award was issued by the Indian Health Service (IHS), a civilian agency within the U.S. Department of Health and Human Services, to Medtox Laboratories Inc., a division of Laboratory Corporation of America Holdings. The $23,490.34 firm-fixed-price delivery order was placed against Medtox's General Services Administration (GSA) Multiple Award Schedule (MAS) contract. The contract provides laboratory supplies, including drug screening test kits, analyzer test cartridges, and general lab supplies, to support clinical testing and substance abuse screening programs at IHS facilities across several states. This award has no set-aside designation and is intended to enable IHS to maintain necessary medical capabilities and deliver quality healthcare to Native American communities through June 2025.

Generated 9/8/24, 9:07 AM